Foshan Shengming Technology Co., Ltd. – Trademark Portfolio

Entity Type: 16

Foshan Shengming Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VITALUMINA and VITANESTICA. The owner is based in Foshan, Guangdong.

Shop No. 07, 2F, Block B, Foshan Shiwan

Sanitary Ware City, Chancheng District

Foshan, Guangdong 528000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Foshan Shengming Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Foshan Shengming Technology Co., Ltd. have?

Foshan Shengming Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Foshan Shengming Technology Co., Ltd. file in?

Foshan Shengming Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Foshan Shengming Technology Co., Ltd.'s most well-known trademarks?

Foshan Shengming Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as VITALUMINA and VITANESTICA. These are among 2 currently registered trademarks in the portfolio.

What is Foshan Shengming Technology Co., Ltd.'s trademark registration success rate?

Foshan Shengming Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.